Compliance with psychotropic medication treatment among adolescents living in youth care centres

Children and Youth Services Review

Volumn 32, Issue 1, 2010, Pages 67-73

  Laurier, Catherine ^a   Lafortune, Denis ^b   Collin, Johanne ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adolescents; Compliance; Linear regression; Psychotropic medication; Youth care centres

Indexed keywords

EID: 70450240852     PISSN: 01907409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.childyouth.2009.07.007     Document Type: Article

References (58)

1. Achenbach T.M. Manual for the youth self-report form and 1991 profile (1991), University of Vermont, Department of Psychiatry, Burlington
2. Baillargeon J., Contreras S., Grady J.J., Black S.A., and Murray O. Compliance with antidepressant medication among prison inmates with depressive disorders. Psychiatric Services 51 11 (2000) 1444-1446
3. Bastiaens L. Compliance with pharmacotherapy in adolescents: Effects of patients' and parents' knowledge and attitudes toward treatment. Journal of Child and Adolescent Psychopharmacology 5 1 (1995) 39-48
4. Bastiaens L., Chowdhury S., and Gitelman L. Medication samples and drug compliance. Psychiatric Services 51 6 (2000) 819
5. Baumann M., and Trincard M. Les attitudes d'autonomie dans la compliance thérapeutique d'une cohorte de consommateurs continues de psychotropes. Encephale 28 5 Pt 1 (2002) 389-396
6. Beck C.A., Williams J., Wang J.L., Kassam A., El-Guebaly N.C., Maxwell C.J., et al. Psychotropic medication use in Canada. Canadian Journal of Psychiatry 50 10 (2005) 605-613
7. Becker M.H., and Mainman L.A. Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care 13 1 (1975) 10-24
8. Bergeron J., Landry M., Brochu S., and Cournoyer L.-G. Les déterminants de la persévérance des clients dans les traitements de réadaptation pour l'alcoolisme et la toxicomanie : une approche multidimensionnelle. Rapport d'une recherche subventionnée par le Conseil québécois de la recherche sociale (# RS 2308-093) (1997), Bibliothèque nationale du Québec, Québec
9. Björkqvist K., Lagerspetz K.M.J., and Österman K. The Direct and Indirect Aggression Scales (1992), Abo Akademi University, Findland
10. Bourgeois J.A. Compliance with psychiatric treatment in primary care: Review and strategies. Primary Psychiatry 12 6 (2005) 40-47
11. Breland-Noble A.M., Elbogen E.B., Farmer E.M.Z., Dubs M.S., Wagner H.R., and Burns B.J. Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatric Services 55 6 (2004) 706-708
12. Burlingame G.M., Dunn T.W., Chen S., Lehman A., Axman R., Earnshaw D., et al. Selection of outcome assessment instrument for inpatients with severe and persistent mental illness. Psychiatric Services 56 4 (2005) 444-451
13. Bush P.J., and Iannotti R.J. A children's health belief model. Medical Care 28 1 (1990) 69-86
14. Chappuy H., Tréluyer J.-M., Gary A., Pons G., and Chéron G. Compliance médicamenteuse chez l'enfant. Archives de Pédiatrie 12 (2005) 921-923
15. Cramer J.A., and Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services 49 2 (1998) 196-201
16. DosReis S., Zito J.M., Safer D.J., and Soeken K.L. Mental health services for youths in foster care and disabled youths. American Journal of Public Health 91 7 (2001) 1094-1099
17. DosReis S., Zito J.M., Safer D.J., Soeken K.L., Mitchell Jr. J.W., and Ellwood L.C. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics 24 3 (2003) 155-162
18. Ellis S., Shumaker S., Sieber W., and Rand C. Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Controlled Clinical Trials 21 5 Suppl (2000) 218S-225S
19. Endler N.S. Stress, anxiety and coping: The multidimensional interaction model. Canadian Psychology 38 3 (1997) 136-153
20. Endler N.S., and Parker J.D.A. CISS: Coping Inventory for Stressful Situations. Manual (1990), Multi-health Systems Inc., Toronto, Ontario 71 pp
21. Gaston L. Reliability and criterion-related validity of the California Psychotherapy Alliance Scales-Patient version. Psychological Assessment: A Journal of Consulting and Clinical Psychology 3 (1991) 68-74
22. Ghaziuddin N., King C.A., Hovey J.D., Zaccagnini J., and Ghaziuddin M. Medication noncompliance in adolescents with psychiatric disorders. Child Psychiatry and Human Development 30 2 (1999) 103-110
23. Grasset F., Bonvin E., and Pomini V. Pharmacothérapie psychotrope, compliance au traitement et compliance des prescriptions. Revue Médicale de la Suisse Romande 120 2 (2000) 137-143
24. Greenhill L.L., and Setterberg S. Pharmacotherapy of disorders of adolescents. Psychiatric Clinics of North America 16 4 (1993) 793-814
25. Hack S., and Chow B. Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance. Journal of Child and Adolescent Psychopharmacology 11 1 (2001) 59-67
26. Haynes R.B. Introduction. In: Haynes R.B., Taylor D.W., and Sackett D.L. (Eds). Compliance in health care (1979), Johns Hopkins University Press, Baltimore 1-7
27. Horne R., and Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research 47 6 (1999) 555-567
28. Hugues C.W., Rintelmann J., Emslie G.J., Lopez M., and MacCabe N. A revised anchored version of the BPRS-C for childhood psychiatric disorders. Journal of Child and Adolescent Psychopharmacology 11 1 (2001) 77-93
29. Keable P., and Laframboise J. Cueillette d'informations sur la clientèle hébergée au CJM-IU en vertu de mesures de type youth care centres, dans le cadre de la LSSSS, de la LPJ ou de la LSJPA (2005), Centre jeunesse de Montreal-Institut Universitaire, Montreal Rapport de recherche inédit
30. Lachar D., Randle S.L., Harper R.A., Scott-Gurnell K.C., Lewis K.R., Santos C.W., et al. The Brief Psychiatric Rating Scale for Children (BPRS-C): Validity and reliability of an anchored version. Journal of the American Academy of Child and Adolescent Psychiatric 40 3 (2001) 333-340
31. Lafortune D., and Laurier C. Le recours aux médicaments psychotropes dans la prise en charge des jeunes hébergés dans les Centres Jeunesse. In: Guyon L., Brochu S., and Landry M. (Eds). Les jeunes et les drogues (2005), Presses de l'Université Laval, Québec 203-233
32. Lafortune D., Laurier C., and Gagnon F. Prévalence et facteurs associés à la prescription de médicaments psychotropes chez les sujets placés en Centre Jeunesse. Revue de Psychoéducation 33 1 (2004) 157-176
33. Lagueux F., Wright J., and Tourigny M. Mise sur pied d'un protocole d'évaluation dans le cadre de l'étude: Évaluation d'un programme de traitement pour adolescents agresseurs sexuels (AAS). Document inédit (1999), Université de Montreal, Montreal
34. Laurier C., and Lafortune D. Les facteurs contribuant à l'observance d'une psychopharmacothérapie chez les adolescents hébergés en centres de réadaptation. Psychologie Canadienne/Canadian Psychology 48 4 (2007) 211-220
35. Laurier C., and Lafortune D. Validation de l'échelle d'évaluation des comportements et des attitudes d'observance des prescriptions psychopharmacologiques (ÉCAOPP). Canadian Journal of Behavioural Science 39 4 (2007) 326-338
36. Leo R.J., Jassal K., and Bakhai Y.D. Nonadherence with psychopharmacologic treatment among psychiatric patients. Primary Psychiatry 12 6 (2005) 33-39
37. Lerner B.H. From careless consumptives to recalcitrant patients: The historical construction of non-compliance. Social Sciences and Medicine 45 9 (1997) 1423-1431
38. Les Centres Jeunesse du Québec. Bilan des Directeurs de la Protection de la Jeunesse-2006 (2006), Association des Centres Jeunesse du Québec-Service des communications 46 pp
39. Major S. Relations entre les attitudes envers l'alcool et les drogues et la motivation au changement (1994), Mémoire de maîtrise, Université de Montreal, Montreal, Québec, Canada
40. Martin A., Van Hoof T., Stubbe D., Sherwin T., and Scahill L. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid Managed Care. Psychiatric Services 54 1 (2003) 72-77
41. Meichenbaum D., and Turk D.C. Facilitating treatment adherence (1987), Plenum Press, New York
42. Mercier C. Le rôle des facteurs subjectifs dans la fidélité à la médication. Revue Canadienne de Psychiatrie 34 (1989) 662-667
43. McConnaughy E.A., Prochaska J.O., and Velicer W.F. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research and Practice 20 (1983) 368-375
44. Morasse C. Ton comportement (agressivité). Volet 1 : Portrait des jeunes inscrits à la prise en change des Centres jeunesse du Québec et description des services reçus au cours des huit premiers mois (1999), Fonds pour l'adaptation des services de santé (FASS)
45. Overall J.E., and Pfeffernaum B. The Brief Psychiatric Rating Scale for Children. Psychopharmacology Bulletin 18 (1982) 10-16
46. Prochaska J.O., DiClemente C.C., and Norcross J.C. In search of how people change: Applications to addictive behaviors. American Psychologist 47 (1992) 1102-1114
47. Raghavan R., Zima B.T., Anderson R.M., Leibowitz A.A., Schuster M.A., and Landsverk J. Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology 15 1 (2005) 97-106
48. Rolland J.P. Inventaire de coping pour situations stressantes CISS (manuel, adaptation française) (1998), Editions du centre de psychologie appliquée, Paris
49. Safer D.J., Zito J.M., and Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98 6 (1996) 1084-1088
50. Stein M.B., Cantrell C.R., Sokol M.C., Eady M.T., and Shah M.B. Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatric Services 57 5 (2006) 673-680
51. The Research Units on Pediatric Psychopharmacology Anxiety Study Group. Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 42 1 (2003) 13-21
52. Thiruchelvam D., Charach A., and Schachar R.J. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 40 8 (2001) 922-928
53. Vermeire E., Hearnshaw H., Van Royen P., and Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics 26 5 (2001) 331-342
54. Williams R.A., Hollis H.M., and Benoit K. Attitudes toward psychiatric medications among incarcerated female adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 37 12 (1998) 1301-1307
55. World Health Organization. World Health Organization tackles problem of poor treatment adherence. Psychiatric Services 54 7 (2003) 1052-1053
56. Wyss C.A., Voelker S.L., Cornock B.L., and Hakim-Larson J. Psychometric properties of a French-Canadian Translation of Achenbach's Youth Self-Report. Canadian Journal of Behavioural Science 35 1 (2003) 67-71
57. Zima B.T., Bussing R., Crecelius G.M., Kaufman A., and Belin T.R. Psychotropic medication use among children in foster care: Relationship to severe psychiatric disorders. American Journal of Public Health 89 11 (1999) 1732-1735
58. Zito J.M., Safer D.J., DosReis S., Gardner J.F., Magder L., Soeken K., et al. Psychotropic practice patterns for youths: A 10-years perspective. Archives of Pediatrics & Adolescent Medicine 157 1 (2003) 17-25